Robert L. Marcotte
Thank you, Catherine. Good morning, and thank you all for dialing in this morning. I'll cover the highlights for the quarter and a few subsequent events and some comments on our near-term outlook for the company. Beginning with our last quarter results, fundings last quarter totaled $73 million and included 2 new PE-sponsored investments in the health care and industrial manufacturing sectors. Exits and prepayments remained elevated at $82 million as we exited 2 sizable investments in the aerospace and restaurant industries. So net originations were a negative $9 million for the period as the bulk of the new deal pipeline we discussed last quarter slipped past the quarter end. Interest income for the period fell slightly to $20.9 million, largely as a result of the 5.2% decline in the average earning assets. However, the weighted average portfolio yield rose 20 basis points to 12.8% for the quarter with onetime items associated with the prepayments. Interest and financing costs fell 8.8% with lower bank borrowings, while net management fees rose $0.5 million as incentive fee credits declined to $700,000. And net investment income was flat at $11.3 million for the period. Net realized losses were $3.6 million for the quarter, the bulk of which was related to the post-restructuring valuation of our investment in EGs, which is now a performing debt investment. One of the larger contributors to the unrealized depreciation for the quarter was our printed circuit board investment, which hit a slowdown in bookings, which we are addressing. However, on balance, the portfolio appreciation offset the decliners. So for the TTM period, our ROE came in at a respectable 15.8%. With respect to the portfolio, the portfolio turnover for the period did not have a material impact on our investment mix as new originations were predominantly first lien debt, which was maintained at 70% of the fair value of the portfolio, and total debt holdings came in at 90% of the portfolio at fair value. As of the end of the quarter, we had 3 nonearning debt investments with a cost basis of $28.8 million or $11.5 million or 1.7% of our debt investments at fair value. As I mentioned earlier, since the end of the quarter, we've been busy working through our deal pipeline and have closed on 4 new platform investments and an add-on, bringing July and early August originations to $93 million and net of the $3.8 million payoff of our last material broadly syndicated loan, net originations for July and early August were $89 million. And while I'm sure I'll get some questions about the recent spike in investment activity in face of the broader market conditions, our core strategy of focusing on growth-oriented lower middle-market investments backed by PE sponsors is unchanged. For context, of the 8 deals funded since the end of last quarter and thus far this quarter, which have totaled $159 million, 88% were first-lien investments with an average closing leverage of 3x EBITDA and an average margin over SOFR of in excess of 7%. And reflecting on our outlook for the next quarter or 2, I'd like to leave you with a couple of comments. The vast majority of the anticipated portfolio events are behind us. And between our remaining new deal pipeline and new investment opportunities, we anticipate a resurgence in our portfolio growth. Market volatility aside, we continue to see a healthy flow of attractive lower middle-market deal opportunities and are thrilled to have closed deals with 6 new sponsors since March 30. In addition to recycling the wave of investment exits in the past couple of quarters, we expect to continue to benefit from our incumbent position as the originator, lead lender and in some cases, equity co-investor in the newer vintage growth-oriented businesses closed recently as they look to grow through acquisition or expansion and support the appreciation of their equity position. We ended the quarter with a conservative leverage position with debt at 64% of NAV and the bulk of our upsized and renewed bank credit facility available to support the growth of our earning assets in the next couple of quarters. Now I'd like to turn the call over to Nicole Schaltenbrand, Gladstone Capital's CFO, to provide some details on the fund results for the quarter.